1. Home
  2. CMDB vs DCTH Comparison

CMDB vs DCTH Comparison

Compare CMDB & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Costamare Bulkers Holdings Limited

CMDB

Costamare Bulkers Holdings Limited

SELL

Current Price

$20.46

Market Cap

507.2M

Sector

N/A

ML Signal

SELL

DCTH

Delcath Systems Inc.

SELL

Current Price

$15.67

Market Cap

578.4M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CMDB
DCTH
Founded
2023
1988
Country
Monaco
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
507.2M
578.4M
IPO Year
2024
2015

Fundamental Metrics

Financial Performance
Metric
CMDB
DCTH
Price
$20.46
$15.67
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
★ $24.00
AVG Volume (30 Days)
51.3K
★ 317.5K
Earning Date
11-13-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 107.53
EPS
N/A
★ 0.04
Revenue
N/A
N/A
Revenue This Year
N/A
$24.61
Revenue Next Year
N/A
$24.27
P/E Ratio
★ N/A
$384.63
Revenue Growth
N/A
N/A
52 Week Low
$12.29
$8.12
52 Week High
$24.76
$17.42

Technical Indicators

Market Signals
Indicator
CMDB
DCTH
Relative Strength Index (RSI) 41.94 49.85
Support Level $16.35 $15.68
Resistance Level $23.16 $16.51
Average True Range (ATR) 0.93 0.54
MACD -0.34 -0.06
Stochastic Oscillator 14.55 63.71

Price Performance

Historical Comparison
CMDB
DCTH

About CMDB Costamare Bulkers Holdings Limited

Costamare Bulkers Holdings Ltd is an international owner and operator of dry bulk vessels providing transportation of dry bulk commodities globally for a broad range of customers. Its vessels transport a broad range of bulks, such as iron ore, coal and grains and minor bulks, such as bauxite, phosphate fertilizers and steel products, across shipping routes globally. The company's vessel fleet includes Current Dry Bulk Fleet, Chartered-In Vessels Fleet, and Chartered-In Newbuilding Vessels. It operates under one reportable segment, that of operating dry bulk vessels.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: